SHL Telemedicine Statistics

Total Valuation

SHL Telemedicine has a market cap or net worth of CHF 40.65 million. The enterprise value is 41.13 million.

Market Cap	40.65M
Enterprise Value	41.13M

Important Dates

The next estimated earnings date is Friday, December 27, 2024.

Earnings Date	Dec 27, 2024
Ex-Dividend Date	n/a

Share Statistics

SHL Telemedicine has 16.39 million shares outstanding. The number of shares has increased by 5.37% in one year.

Current Share Class	n/a
Shares Outstanding	16.39M
Shares Change (YoY)	+5.37%
Shares Change (QoQ)	-0.50%
Owned by Insiders (%)	13.41%
Owned by Institutions (%)	73.82%
Float	12.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.82
PB Ratio	0.67
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.18
EV / Sales	0.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-360.40

Financial Position

The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.25.

Current Ratio	2.17
Quick Ratio	1.98
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	-141.03
Interest Coverage	-2.61

Financial Efficiency

Return on equity (ROE) is -11.51% and return on invested capital (ROIC) is -4.70%.

Return on Equity (ROE)	-11.51%
Return on Assets (ROA)	-4.07%
Return on Capital (ROIC)	-4.70%
Revenue Per Employee	86,221
Profits Per Employee	-13,625
Employee Count	583
Asset Turnover	0.50
Inventory Turnover	8.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.57% in the last 52 weeks. The beta is 0.38, so SHL Telemedicine's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-69.57%
50-Day Moving Average	2.62
200-Day Moving Average	4.13
Relative Strength Index (RSI)	48.20
Average Volume (20 Days)	1,817

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHL Telemedicine had revenue of CHF 50.27 million and -7.94 million in losses. Loss per share was -0.57.

Revenue	50.27M
Gross Profit	22.99M
Operating Income	-6.51M
Pretax Income	-7.17M
Net Income	-7.94M
EBITDA	-4.20M
EBIT	-6.51M
Loss Per Share	-0.57

Full Income Statement

Balance Sheet

The company has 18.26 million in cash and 16.09 million in debt, giving a net cash position of 2.17 million or 0.13 per share.

Cash & Cash Equivalents	18.26M
Total Debt	16.09M
Net Cash	2.17M
Net Cash Per Share	0.13
Equity (Book Value)	63.14M
Book Value Per Share	3.69
Working Capital	16.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.30 million and capital expenditures -1.42 million, giving a free cash flow of -114,122.

Operating Cash Flow	1.30M
Capital Expenditures	-1.42M
Free Cash Flow	-114,122
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 45.73%, with operating and profit margins of -12.95% and -15.80%.

Gross Margin	45.73%
Operating Margin	-12.95%
Pretax Margin	-14.26%
Profit Margin	-15.80%
EBITDA Margin	-8.35%
EBIT Margin	-12.95%
FCF Margin	-0.23%

Dividends & Yields

SHL Telemedicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.37%
Shareholder Yield	-5.37%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHL Telemedicine has an Altman Z-Score of 1.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.71
Piotroski F-Score	n/a